Comparing gut and skin bacteria in people with vitiligo and healthy people
Compares gut and skin microbes in people with vitiligo and healthy adults.
Key facts
- Who runs it
- Northwestern University
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- The Gut and Skin Microbiome in Vitiligo Disease Progression
- Status
- Recruiting
- People taking part
- 100 people, planned
- Started
- 30 May 2019
- Expected to end
- Dec 2026
- Type of study
- Observational, 2 groups
- Record updated
- 9 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with vitiligo, with active or stable disease, and adults without vitiligo of similar age and sex. It compares the bacteria in the gut and on the skin.
- Age
- 18 to 89 years
- Sex
- All sexes
- Disease stage
- Vitiligo with or without spreading of the patches over the past year. People without vitiligo can join as a comparison group.
Main reasons for not taking part
- Younger than 18 years or 90 years or older
- Not able to give consent
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Patients with and/or without vitiligo lesional expansion over the past year
- Age/sex-matched controls who do not have a diagnosis of vitiligo
- Subjects who are age 18-89 years of age at time of enrollment
- Subjects who are able and willing to give informed consent for this study and the Dermatology Tissue Acquisition and Biorepository (STU00009443)
Who cannot take part
- Subjects who are younger than 18 years of age or 90 years of age or older
- Subjects who are unable to give consent
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 89 years old?
Where in United States
- Northwestern UniversityChicago, United StatesContact: Dermatology CTUTaking people
About the trial
What the trial wants to find out
Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.
The 2 groups in the trial
- Adults with vitiligo
- Healthy adults
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Gut and Skin Microbiome in Vitiligo Disease Progression
- Plain-language title
- Comparing gut and skin bacteria in people with vitiligo and healthy peopleGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT03577327, who can take part
- Record updated
- 9 June 2026